Specifically, the individual roles of pro-inflammatory cytokines to modulate insulin sensitivity in skeletal muscle and adipose tissue should be identified to determine whether inflammation is indeed active in metabolic diseases similar to that observed in humans. The gene discussed is INS; the disease is metabolic disease.